Effects of N-acetylcysteine on Diabetic Foot Oxygenation

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether N-acetylcysteine is effective in the treatment or prevention of the foot ulcers in diabetic patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Turin, Italy
• Treatments: Acetylcysteine; N-monoacetylcystine

Criteria

Inclusion Criteria:

• Age between 45 and 70 years.

• Type 1 or 2 diabetes mellitus with foot ulcer (grade 0 stage C according to Texas University Classification).

• Written informed consent.

Exclusion Criteria:

• N-acetylcysteine assumption in the 6 months previous to the study.

• Hypersensibility to acetylcysteine.

• Neoplasms, severe systemic, hepatic, pulmonary, cardiovascular or renal diseases.

• Psychiatric diseases or drug abuse problems.